Drawing First Blood: Biomarkers and TAVR Outcomes
- PMID: 38939396
- PMCID: PMC11198460
- DOI: 10.1016/j.jacadv.2023.100760
Drawing First Blood: Biomarkers and TAVR Outcomes
Keywords: aortic stenosis; biomarkers; transcatheter aortic valve replacement.
Conflict of interest statement
The author has reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
- doi: 10.1016/j.jacadv.2023.100761
References
-
- Coisne A., Scotti A., Latib A., et al. Impact of moderate aortic stenosis on long-term clinical outcomes: a systematic review and meta-analysis. J Am Coll Cardiol Intv. 2022;15:1664–1674. - PubMed
-
- Généreux P., Pibarot P., Redfors B., et al. Evolution and prognostic impact of cardiac damage after aortic valve replacement. J Am Coll Cardiol. 2022;80:783–800. - PubMed
-
- Sarkar A., Chowdhury S., Kumar A., et al. Biomarkers as prognostic markers for aortic stenosis: a review. Am J Cardiol. 2023;206:53–59. - PubMed
-
- Hecht S., Giuliani C., Nuche J., et al. Multimarker approach to improve risk stratification of patients undergoing transcatheter aortic valve implantation. JACC: Adv. 2024;3(2)
Publication types
LinkOut - more resources
Full Text Sources